Zacks Research Comments on Tenet Healthcare Co.'s Q4 2024 Earnings (NYSE:THC)

Tenet Healthcare Co. (NYSE:THC - Free Report) - Zacks Research raised their Q4 2024 EPS estimates for shares of Tenet Healthcare in a research report issued on Tuesday, May 14th. Zacks Research analyst D. Chatterjee now forecasts that the company will post earnings of $2.12 per share for the quarter, up from their previous estimate of $1.89. The consensus estimate for Tenet Healthcare's current full-year earnings is $8.73 per share. Zacks Research also issued estimates for Tenet Healthcare's Q2 2025 earnings at $1.63 EPS, FY2025 earnings at $7.14 EPS, Q1 2026 earnings at $2.46 EPS and FY2026 earnings at $8.83 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Tuesday, April 30th. The company reported $3.22 EPS for the quarter, beating analysts' consensus estimates of $1.45 by $1.77. The business had revenue of $5.37 billion for the quarter, compared to analysts' expectations of $5.15 billion. Tenet Healthcare had a net margin of 12.53% and a return on equity of 26.76%. The company's quarterly revenue was up 6.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.42 EPS.

Other equities analysts have also recently issued reports about the stock. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $104.00 price target on shares of Tenet Healthcare in a research note on Wednesday, April 10th. Barclays boosted their price objective on shares of Tenet Healthcare from $113.00 to $147.00 and gave the stock an "overweight" rating in a research report on Thursday, May 2nd. TheStreet upgraded shares of Tenet Healthcare from a "c+" rating to a "b-" rating in a research report on Tuesday, February 6th. Truist Financial reiterated a "buy" rating and issued a $130.00 price objective (up from $120.00) on shares of Tenet Healthcare in a research report on Wednesday, May 1st. Finally, Wells Fargo & Company boosted their price objective on shares of Tenet Healthcare from $105.00 to $115.00 and gave the stock an "overweight" rating in a research report on Thursday, March 28th. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Tenet Healthcare has a consensus rating of "Buy" and an average target price of $113.19.

Tenet Healthcare Stock Performance

THC traded up $4.38 during trading on Wednesday, hitting $132.94. The stock had a trading volume of 1,647,288 shares, compared to its average volume of 1,229,094. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.37 and a current ratio of 1.44. The firm has a market capitalization of $12.99 billion, a P/E ratio of 5.11, a PEG ratio of 1.28 and a beta of 2.09. The company's 50-day moving average price is $104.99 and its 200 day moving average price is $86.27. Tenet Healthcare has a twelve month low of $51.04 and a twelve month high of $133.17.

Insider Activity

In related news, EVP Paola M. Arbour sold 18,168 shares of the stock in a transaction that occurred on Wednesday, March 6th. The shares were sold at an average price of $96.96, for a total transaction of $1,761,569.28. Following the completion of the sale, the executive vice president now owns 29,803 shares of the company's stock, valued at approximately $2,889,698.88. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, EVP Paola M. Arbour sold 18,168 shares of the stock in a transaction that occurred on Wednesday, March 6th. The shares were sold at an average price of $96.96, for a total transaction of $1,761,569.28. Following the completion of the sale, the executive vice president now owns 29,803 shares of the company's stock, valued at approximately $2,889,698.88. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Nadja West sold 1,782 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $126.41, for a total transaction of $225,262.62. Following the sale, the director now directly owns 29,680 shares of the company's stock, valued at approximately $3,751,848.80. The disclosure for this sale can be found here. Insiders sold a total of 61,598 shares of company stock valued at $6,238,815 in the last 90 days. 0.93% of the stock is currently owned by insiders.

Institutional Trading of Tenet Healthcare

Large investors have recently bought and sold shares of the company. Nordea Investment Management AB lifted its stake in Tenet Healthcare by 324.3% during the fourth quarter. Nordea Investment Management AB now owns 40,066 shares of the company's stock worth $3,030,000 after purchasing an additional 30,623 shares during the last quarter. First Eagle Investment Management LLC lifted its stake in Tenet Healthcare by 37.3% during the third quarter. First Eagle Investment Management LLC now owns 176,404 shares of the company's stock worth $11,623,000 after purchasing an additional 47,952 shares during the last quarter. Levin Capital Strategies L.P. bought a new position in Tenet Healthcare during the fourth quarter worth $1,684,000. Bleakley Financial Group LLC lifted its stake in Tenet Healthcare by 6.0% during the fourth quarter. Bleakley Financial Group LLC now owns 91,159 shares of the company's stock worth $6,889,000 after purchasing an additional 5,198 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Tenet Healthcare by 0.6% during the third quarter. Vanguard Group Inc. now owns 10,937,483 shares of the company's stock worth $720,671,000 after purchasing an additional 63,253 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.